Viewing Study NCT01756404


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2026-06-17 @ 7:33 PM
Study NCT ID: NCT01756404
Status: COMPLETED
Last Update Posted: 2018-12-13
First Post: 2012-12-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Otherwise Healthy Obese Volunteers
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Healthy View
None Canagliflozin (JNJ-28431754) View
None Pharmacokinetics View
None Pharmacodynamics View
None Obesity View